SelectScience InterviewsLife Sciences
Why glycosylation is the missing piece in cancer research
13 May 2026
Discover how glycobiology is transforming cancer research by revealing critical glycosylation patterns invisible to traditional proteomics. In this SelectScience interview, Erika Leonard, Director of R&D at Vector Laboratories , explains how validated lectins and advanced glycan‑binding tools bring spatial insight, reproducibility, and confidence to multiomic workflows, helping researchers better understand the tumor microenvironment and advance therapeutic discovery.
This video was filmed at AACR Annual Meeting 2026.
About the company

Vector Laboratories Inc.
Other videos from Vector Laboratories Inc.
Links
Tags
GlycobiologyGlycobiology encompasses research into the biological functions, synthesis and structures of glycans, including glycoproteins, glycolipids, proteoglycans and free oligosaccharides. Mass spectrometers and their software are commonly used in the study of glycobiology, along with structure predicting tools, chromatography and NMR.AACRThe American Association for Cancer Research (AACR) is a leading organization focused on cancer research and treatment. It provides a platform for scientists, healthcare professionals, and industry leaders to share knowledge and collaborate in the fight against cancer.LectinCancer ResearchCancer research aims to understand the mechanisms of cancer development and progression to improve prevention, diagnosis, and treatment. From molecular biology to clinical trials, research spans a wide range of disciplines, including immunotherapy, targeted therapies, and drug discovery. Explore the best cancer research products in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.


